Betulin Elicits Anti-Cancer Effects in Tumour Primary Cultures and Cell Lines in Vitro

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 6, 2009, Pages 425-432

  Rzeski, Wojciech ^a,c   Stepulak, Andrzej ^c,d   Szymański, Marek ^e   Juszczak, Małgorzata ^b   Grabarska, Aneta ^c   Sifringer, Marco ^f   Kaczor, Józef ^a   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d Ministry of Interior and Administration Republic of Poland Central Clinical Hospital   (Poland)

^e NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LUNG CARCINOMA; MALE; MEDULLOBLASTOMA; MULTIPLE MYELOMA; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SKIN FIBROBLAST; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRITERPENES; TUMOR CELLS, CULTURED;

BETULA PENDULA;

EID: 70449674494     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00471.x     Document Type: Article

References (26)

1. Butler MS. Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 2005 22 : 162 195.
2. Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 2006 29 : 1 13.
3. Krasutsky PA. Birch bark research and development. Nat Prod Rep 2006 23 : 919 942.
4. Sun IC, Wang HK, Kashiwada Y, Shen JK, Cosentino LM, Chen CH et al. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. J Med Chem 1998 41 : 4648 4657.
5. Gong Y, Raj KM, Luscombe CA, Gadawski I, Tam T, Chu J et al. The synergistic effects of betulin with acyclovir against herpes simplex viruses. Antiviral Res 2004 64 : 127 130.
6. Hwang BY, Chai HB, Kardono LB, Riswan S, Farnsworth NR, Cordell GA et al. Cytotoxic triterpenes from the twigs of Celtis philippinensis. Phytochemistry 2003 62 : 197 201.
7. Huyke C, Reuter J, Rodig M, Kersten A, Laszczyk M, Scheffler A et al. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. J Dtsch Dermatol Ges 2009 7 : 128 133.
8. Wada S, Iida A, Tanaka R. Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. J Nat Prod 2001 64 : 1545 1547.
9. Beretta GL, Perego P, Zunino F. Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors. Expert Opin Ther Targets 2008 12 : 1243 1256.
10. Rzeski W, Stepulak A, Szymanski M, Sifringer M, Kaczor J, Wejksza K et al. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch Pharmacol 2006 374 : 11 20.
11. LoPiccolo J, Granville CA, Gills JJ, Dennis PA. Targeting Akt in cancer therapy. Anticancer Drugs 2007 18 : 861 874.
12. New DC, Wu K, Kwok AW, Wong YH. G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis. FEBS J 2007 274 : 6025 6036.
13. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007 26 : 3291 3310.
14. Emanuele S, Lauricella M, Tesoriere G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). Int J Oncol 2008 33 : 637 646.
15. Ehrhardt H, Fulda S, Fuhrer M, Debatin KM, Jeremias I. Betulinic acid-induced apoptosis in leukemia cells. Leukemia 2004 18 : 1406 1412.
16. Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 1999 82 : 435 441.
17. Pyo JS, Roh SH, Kim DK, Lee JG, Lee YY, Hong SS et al. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. Planta Med 2009 75 : 127 131.
18. Urban M, Sarek J, Kvasnica M, Tislerova I, Hajduch M. Triterpenoid pyrazines and benzopyrazines with cytotoxic activity. J Nat Prod 2007 70 : 526 532.
19. Gao H, Wu L, Kuroyanagi M, Harada K, Kawahara N, Nakane T et al. Antitumor-promoting constituents from Chaenomeles sinensis KOEHNE and their activities in JB6 mouse epidermal cells. Chem Pharm Bull (Tokyo) 2003 51 : 1318 1321.
20. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME et al. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998 273 : 33942 33948.
21. Oh SH, Choi JE, Lim SC. Protection of betulin against cadmium-induced apoptosis in hepatoma cells. Toxicology 2006 220 : 1 12.
22. Muceniece R, Saleniece K, Riekstina U, Krigere L, Tirzitis G, Ancans J. Betulin binds to melanocortin receptors and antagonizes alpha-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells. Cell Biochem Funct 2007 25 : 591 596.
23. Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 2007 1773 : 1161 1176.
24. Tokunaga E, Oki E, Egashira A, Sadanaga N, Morita M, Kakeji Y et al. Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 2008 8 : 27 36.
25. Jager S, Laszczyk MN, Scheffler A. A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 2008 13 : 3224 3235.
26. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949 96 : 99 113.